These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8935172)

  • 1. Studies with inhibitors of the glycolytic enzyme phosphoglycerate kinase for potential treatment of cardiovascular and respiratory disorders.
    Mcharg J; Littlechild JA
    J Pharm Pharmacol; 1996 Feb; 48(2):201-5. PubMed ID: 8935172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism.
    Bernstein BE; Hol WG
    Biochemistry; 1998 Mar; 37(13):4429-36. PubMed ID: 9521762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on the complexes between human erythrocyte enzymes participating in the conversions of 1,3-diphosphoglycerate.
    Fokina KV; Dainyak MB; Nagradova NK; Muronetz VI
    Arch Biochem Biophys; 1997 Sep; 345(2):185-92. PubMed ID: 9308888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphonate inhibitors of glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate kinase.
    Li YK; Byers LD
    Biochim Biophys Acta; 1993 Jun; 1164(1):17-21. PubMed ID: 8518293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halibut muscle 3-phosphoglycerate kinase. Chemical and physical properties of the enzyme and its substrate complexes.
    Huskins KR; Bernhard SA; Dahlquist FW
    Biochemistry; 1982 Aug; 21(17):4180-8. PubMed ID: 6982068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anion activation of 3-phosphoglycerate kinase requires domain closure.
    Szilágyi AN; Vas M
    Biochemistry; 1998 Jun; 37(23):8551-63. PubMed ID: 9622507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of MK-401 against Fasciola hepatica: inhibition of phosphoglycerate kinase.
    Schulman MD; Ostlind DA; Valentino D
    Mol Biochem Parasitol; 1982 Mar; 5(3):133-45. PubMed ID: 7088033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic binding of substrates to 3-phosphoglycerate kinase monitored by the fluorescent analogue 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate.
    Vas M; Merli A; Rossi GL
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):885-91. PubMed ID: 8053912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallographic and thiol-reactivity studies on the complex of pig muscle phosphoglycerate kinase with ATP analogues: correlation between nucleotide binding mode and helix flexibility.
    Kovári Z; Flachner B; Náray-Szabó G; Vas M
    Biochemistry; 2002 Jul; 41(28):8796-806. PubMed ID: 12102622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide binding to pig muscle 3-phosphoglycerate kinase in the crystal and in solution: relationship between substrate antagonism and interdomain communication.
    Merli A; Szilágyi AN; Flachner B; Rossi GL; Vas M
    Biochemistry; 2002 Jan; 41(1):111-9. PubMed ID: 11772008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of 1,3-diphosphoglycerate between glyceraldehyde-3-phosphate dehydrogenase and 3-phosphoglycerate kinase via an enzyme-substrate-enzyme complex.
    Weber JP; Bernhard SA
    Biochemistry; 1982 Aug; 21(17):4189-94. PubMed ID: 7126536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A futile cycle in erythrocyte glycolysis.
    Black JA; Acott KM; Bufton L
    Biochim Biophys Acta; 1985 Nov; 810(2):246-51. PubMed ID: 4063353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of phosphoglycerate kinase in human erythrocytes. II. Kinetic properties.
    Ali M; Brownstone YS
    Biochim Biophys Acta; 1976 Aug; 445(1):89-103. PubMed ID: 953034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoglycerate kinase from yeast synthesizes guanosine 5'-tetraphosphate.
    García-Díaz M; Canales J; Sillero MA; Sillero A; Cameselle JC
    Biochem Int; 1989 Dec; 19(6):1253-64. PubMed ID: 2635862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bisubstrate analog induces unexpected conformational changes in phosphoglycerate kinase from Trypanosoma brucei.
    Bernstein BE; Williams DM; Bressi JC; Kuhn P; Gelb MH; Blackburn GM; Hol WG
    J Mol Biol; 1998 Jun; 279(5):1137-48. PubMed ID: 9642090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation.
    Ramírez-Bajo MJ; Repiso A; la Ossa PP; Bañón-Maneus E; de Atauri P; Climent F; Corrons JL; Cascante M; Carreras J
    Blood Cells Mol Dis; 2011 Mar; 46(3):206-11. PubMed ID: 21269848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies of the reaction mechanism of rat liver phosphoglycerate kinase in the direction of ADP utilization.
    Lavoinne A; Marchand JC; Chedeville A; Matray F
    Biochimie; 1983 Mar; 65(3):211-20. PubMed ID: 6405813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycolytic enzymes in human erythrocytes: association of glyceraldehyde-3-phosphate dehydrogenase with 3-phosphoglycerate kinase].
    Ashmarina LI; Muronets VI; Nagradova NK
    Biokhimiia; 1994 Jun; 59(6):873-80. PubMed ID: 8075252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mg2+ affects the binding of ADP but not ATP to 3-phosphoglycerate kinase. Correlation between equilibrium dialysis binding and enzyme kinetic data.
    Molnár M; Vas M
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):595-9. PubMed ID: 8343139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of cyclic 2,3-diphosphoglycerate. Isolation and characterization of 2-phosphoglycerate kinase and cyclic 2,3-diphosphoglycerate synthetase from Methanothermus fervidus.
    Lehmacher A; Vogt AB; Hensel R
    FEBS Lett; 1990 Oct; 272(1-2):94-8. PubMed ID: 2226838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.